Profiling of immune-related gene expression in children with familial hypercholesterolaemia

I Narverud1,2, J J Christensen1,2, S S Bakke3

  • 1Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Insights

Children with familial hypercholesterolaemia (FH) show altered immune gene expression, indicating early atherosclerosis. Statin therapy partially reversed these immune changes, suggesting new therapeutic targets.

Area of Science:

  • Immunology
  • Genetics
  • Cardiovascular Research

Background:

  • Atherosclerosis involves immune responses, but early human associations are unclear.
  • Familial hypercholesterolaemia (FH) in children offers a model for studying elevated LDL-cholesterol effects.

Purpose of the Study:

  • To investigate immunological and inflammatory pathways in early atherosclerosis.
  • To examine mRNA expression in peripheral blood mononuclear cells (PBMCs) of children with FH.

Main Methods:

  • Analyzed 587 immune-related mRNA molecules using Nanostring technology.
  • Compared PBMCs from children with FH (n=30) and healthy children (n=21).
  • Assessed FH children before and after statin therapy (n=10).

Main Results:

  • 176 genes (30%) were differentially expressed in FH children (P < 0.05).
  • FH children showed dysregulated pathways including T cells, B cells, and tumor necrosis factor superfamily (TNFSF).
  • Statin therapy reversed the expression of 13 mRNAs in FH children.

Conclusions:

  • FH children exhibit increased immune gene expression in PBMCs, linked to T cells, B cells, and TNFSF.
  • Elevated LDL-cholesterol influences immune gene expression, offering potential therapeutic targets for preventing atherosclerosis progression.
Abstract